Eterna Therapeutics Inc (ERNA)vsInsmed Inc (INSM)
ERNA
Eterna Therapeutics Inc
$0.21
-0.57%
HEALTHCARE · Cap: $7.20M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 60642200% more annual revenue ($606.42M vs $1,000). ERNA leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
ERNA
Avoid21
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+99.9%
Fair Value
$382.98
Current Price
$0.21
$382.77 discount
Intrinsic value data unavailable for INSM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Operating margin of 0.0%
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ERNA
The strongest argument for ERNA centers on Price/Book, Debt/Equity.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : ERNA
The primary concerns for ERNA are EPS Growth, Market Cap, Profit Margin.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
ERNA profiles as a value stock while INSM is a turnaround play — different risk/reward profiles.
ERNA carries more volatility with a beta of 6.87 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
ERNA generates stronger free cash flow (-1M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 21/100). ERNA offers better value entry with a 99.9% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Eterna Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?